FDA Inspection 1095514 — Xinxiang Tuoxin Pharmaceutical Co. Ltd
The FDA completed an inspection of Xinxiang Tuoxin Pharmaceutical Co. Ltd on June 6, 2019 in Xinxiang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xinxiang (China)